NCT05468502
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Shanghai Sixth People's Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Pulmonary Fibrosis
Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.
374 public trials
55 recruiting studies
Pulmonary Fibrosis trial results
- Conditions
- Healthy Participants, Idiopathic Pulmonary Fibrosis, Lung Diseases, +3 more
- Locations
-
- Research Site Glendale, California, United States
NCT05621252
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT06909968
- Conditions
- Cancer, Chronic Disease, Chronic Obstructive Pulmonary Disease, +21 more
- Locations
-
- Rete Cure Palliative AUSL Bologna Bologna, BO, Italy
- U.O. Nefrologia, Dialisi e Trapianto Renale, Policlinico Sant'Orsola Bologna, BO, Italy
- U.O. Pneumologia e Terapia Intensiva Respiratoria, Policlinico Sant'Orsola Bologna, BO, Italy
- U.O. Nefrologia e Dialisi, Ospedale Morgagni-Pierantoni - Ospedale M. Bufalini Forlì, FC, Italy
NCT05366387
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Pulmonology Department, University Hospital, Tours Tours, France
NCT03422068
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Odense University Hospital Odense, Denmark
- HYKS Keuhkosairauksien tutkimusyksikkö Helsinki, Finland
- TYKS Turku, Finland
- Fraunhofer ITEM Hanover, Germany
NCT05185089
- Conditions
- Cough, Idiopathic Pulmonary Fibrosis, Lung Diseases, +7 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- University of California San Francisco, California, United States
- National Jewish Health Denver, Colorado, United States
- Loyola University Chicago Maywood, Illinois, United States
Completed
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
NCT06331624
- Conditions
- IPF, Idiopathic Pulmonary Fibrosis, Lung Diseases, +3 more
- Locations
-
- Newport Native MD, Inc. Newport Beach, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Montefiore Medical Center The Bronx, New York, United States
- Southeastern Research Center Winston-Salem, North Carolina, United States
NCT05321069
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California Los Angeles Los Angeles, California, United States
NCT05537025
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Research Site 1 Copenhagen, Denmark
- Research Site 2 Odense, Denmark
- Research Site 1 Ancona, Italy
- Research Site 2 Florence, Italy